"Pacific Oaks Medical Group is a men's health primary & preventative care provider located in Beverly Hills, CA. We are a LGBTQ+ friendly doctor office providing medical care in equality. Providing quality preventative health services spanning from prostate antigen screening to HIV PrEP pill medication. Our gay friendly doctors also specialize in sexual health such as low testosterone, erectile dysfunction, hormone imbalances and STD testing. Call our office to schedule an in-person appointment today. We also provide virtual doctors appointments with ZocDoc."

During the past decade, Pacific Oaks Medical Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 10 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Oaks Medical Group" #1 sponsor was "Gilead Sciences" with 15 trials, followed by "Glaxo Wellcome" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Abbott" with 5 trials sponsored and "Bristol-Myers Squibb" with 5 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Oaks Medical Group" #1 collaborator was "Dupont Applied Biosciences" with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator, "Triangle Pharmaceuticals" with 2 trials as a collaborator, "Trimeris" with 2 trials as a collaborator and "Agouron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Oaks Medical Group" are "HIV Infections" (35 trials), "HIV-1 Infection" (6 trials), "Acquired Immunodeficiency Syndrome" (2 trials), "Dyslipidemia" (2 trials) and "HIV Infection" (2 trials). Many other conditions were trialed in "Pacific Oaks Medical Group" in a lesser frequency.

Most popular intervention types in "Pacific Oaks Medical Group" are "Drug" (52 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (8 trials), "Zidovudine" (7 trials), "Efavirenz" (6 trials), "Stavudine" (6 trials) and "Didanosine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Oaks Medical Group" are 50 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Pacific Oaks Medical Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Pacific Oaks Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Oaks Medical Group, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".